Catecholamine metabolism: a contemporary view with implications for physiology and medicine
- PMID: 15317907
- DOI: 10.1124/pr.56.3.1
Catecholamine metabolism: a contemporary view with implications for physiology and medicine
Abstract
This article provides an update about catecholamine metabolism, with emphasis on correcting common misconceptions relevant to catecholamine systems in health and disease. Importantly, most metabolism of catecholamines takes place within the same cells where the amines are synthesized. This mainly occurs secondary to leakage of catecholamines from vesicular stores into the cytoplasm. These stores exist in a highly dynamic equilibrium, with passive outward leakage counterbalanced by inward active transport controlled by vesicular monoamine transporters. In catecholaminergic neurons, the presence of monoamine oxidase leads to formation of reactive catecholaldehydes. Production of these toxic aldehydes depends on the dynamics of vesicular-axoplasmic monoamine exchange and enzyme-catalyzed conversion to nontoxic acids or alcohols. In sympathetic nerves, the aldehyde produced from norepinephrine is converted to 3,4-dihydroxyphenylglycol, not 3,4-dihydroxymandelic acid. Subsequent extraneuronal O-methylation consequently leads to production of 3-methoxy-4-hydroxyphenylglycol, not vanillylmandelic acid. Vanillylmandelic acid is instead formed in the liver by oxidation of 3-methoxy-4-hydroxyphenylglycol catalyzed by alcohol and aldehyde dehydrogenases. Compared to intraneuronal deamination, extraneuronal O-methylation of norepinephrine and epinephrine to metanephrines represent minor pathways of metabolism. The single largest source of metanephrines is the adrenal medulla. Similarly, pheochromocytoma tumor cells produce large amounts of metanephrines from catecholamines leaking from stores. Thus, these metabolites are particularly useful for detecting pheochromocytomas. The large contribution of intraneuronal deamination to catecholamine turnover, and dependence of this on the vesicular-axoplasmic monoamine exchange process, helps explain how synthesis, release, metabolism, turnover, and stores of catecholamines are regulated in a coordinated fashion during stress and in disease states.
Similar articles
-
Leaky catecholamine stores: undue waste or a stress response coping mechanism?Ann N Y Acad Sci. 2004 Jun;1018:224-30. doi: 10.1196/annals.1296.027. Ann N Y Acad Sci. 2004. PMID: 15240373 Review.
-
The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines.Pharmacol Ther. 2001 Jul;91(1):35-62. doi: 10.1016/s0163-7258(01)00144-9. Pharmacol Ther. 2001. PMID: 11707293 Review.
-
Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.Endocr Pathol. 2003 Fall;14(3):193-212. doi: 10.1007/s12022-003-0012-4. Endocr Pathol. 2003. PMID: 14586065 Review.
-
Monoamine oxidase and catecholamine metabolism.J Neural Transm Suppl. 1994;41:57-67. doi: 10.1007/978-3-7091-9324-2_7. J Neural Transm Suppl. 1994. PMID: 7931266 Review.
-
Errors introduced by a tritium label in position 8 of catecholamines.Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):34-42. doi: 10.1007/BF00633194. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 2419773
Cited by
-
Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?PLoS One. 2015 May 6;10(5):e0125426. doi: 10.1371/journal.pone.0125426. eCollection 2015. PLoS One. 2015. PMID: 25946206 Free PMC article.
-
Antioxidant-Mediated Modulation of Protein Reactivity for 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite.Chem Res Toxicol. 2016 Jul 18;29(7):1098-107. doi: 10.1021/acs.chemrestox.5b00528. Epub 2016 Jun 15. Chem Res Toxicol. 2016. PMID: 27268734 Free PMC article.
-
Dopamine alters phage morphology to exert an anti-infection effect.Front Microbiol. 2023 Nov 9;14:1272447. doi: 10.3389/fmicb.2023.1272447. eCollection 2023. Front Microbiol. 2023. PMID: 38029195 Free PMC article.
-
Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.Endocr Pathol. 2012 Mar;23(1):4-14. doi: 10.1007/s12022-011-9188-1. Endocr Pathol. 2012. PMID: 22180288 Review.
-
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson's disease.Cell Commun Signal. 2024 Jan 29;22(1):75. doi: 10.1186/s12964-024-01478-0. Cell Commun Signal. 2024. PMID: 38287374 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical